Cardiomyocyte Proliferation for Therapeutic Regeneration

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Cell Biology

Background:

• Cardiovascular disease leads to cardiomyocyte loss, a defect not corrected by current pharmacologic treatments.
• Cardiac regenerative approaches are exploring the induction of endogenous mature cardiomyocyte proliferation.
• Stimulating mature cardiomyocyte renewal is a novel strategy for cardiac tissue regeneration.

Purpose of the Study:

• To review progress in cardiac tissue regeneration through stimulating mature cardiomyocyte renewal.
• To discuss advancements in inducing endogenous cardiomyocyte proliferation for heart repair.
• To highlight the potential of targeting cellular pathways for cardiac regeneration.

Main Methods:

• Targeting developmental and signaling pathways to stimulate cardiomyocyte cell cycle re-entry.
• Utilizing strategies like systemic delivery, epicardial patches, and intramyocardial injection in animal models.
• Employing gene therapy with viral vectors (adenoviral, adeno-associated) for cardiac gene expression.
• Delivering nucleic acids, including anti-microRNAs and microRNA mimetics, to promote cardiomyocyte renewal.

Main Results:

• Several developmental and signaling pathways have been identified that stimulate cell cycle re-entry in mature cardiomyocytes.
• Various delivery methods have shown success in stimulating cardiomyocyte renewal in animal models of cardiac regeneration.
• Gene therapy and nucleic acid delivery have proven effective in promoting cardiomyocyte renewal.
• Limiting off-target growth stimulation in non-cardiomyocytes remains a key challenge for clinical translation.

Conclusions:

• Inducing endogenous mature cardiomyocyte proliferation is a promising frontier in cardiac regeneration.
• Targeted delivery of signaling factors, gene therapy, and nucleic acids are key strategies.
• Overcoming challenges in specificity for non-cardiomyocytes is crucial for developing translatable therapies.